79 related articles for article (PubMed ID: 26572557)
1. 131I therapy mediated by sodium/iodide symporter combined with kringle 5 has a synergistic therapeutic effect on glioma.
Shi S; Zhang M; Guo R; Zhang M; Hu J; Xi Y; Miao Y; Li B
Oncol Rep; 2016 Feb; 35(2):691-8. PubMed ID: 26572557
[TBL] [Abstract][Full Text] [Related]
2. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.
Zhang M; Guo R; Shi S; Miao Y; Zhang Y; Li B
PLoS One; 2014; 9(3):e92326. PubMed ID: 24647588
[TBL] [Abstract][Full Text] [Related]
3. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma through baculovirus: a comparative study with Bac-CMV-hNIS.
Guo R; Zhang R; Pan Y; Xu H; Zhang M; Liang S; Wang L; Zhang Y; Li B
Nucl Med Commun; 2011 May; 32(5):402-9. PubMed ID: 21386735
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma via baculovirus.
Guo R; Tian L; Han B; Xu H; Zhang M; Li B
Nucl Med Biol; 2011 May; 38(4):599-604. PubMed ID: 21531298
[TBL] [Abstract][Full Text] [Related]
6. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
Li W; Tan J; Wang P; Li N; Li C
Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
8. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Kitzberger C; Spellerberg R; Han Y; Schmohl KA; Stauss C; Zach C; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2023 Mar; 29(5):930-942. PubMed ID: 36516189
[TBL] [Abstract][Full Text] [Related]
10. Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (
Schug C; Kitzberger C; Sievert W; Spellerberg R; Tutter M; Schmohl KA; Eberlein B; Biedermann T; Steiger K; Zach C; Schwaiger M; Multhoff G; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2019 Oct; 25(19):5997-6008. PubMed ID: 31196853
[TBL] [Abstract][Full Text] [Related]
11. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow-Derived Mesenchymal Stem Cell-Mediated Dual-Gene Therapy for Glioblastoma.
Shi S; Zhang M; Guo R; Miao Y; Li B
Hum Gene Ther; 2019 Jan; 30(1):106-117. PubMed ID: 29993289
[TBL] [Abstract][Full Text] [Related]
13. Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy.
Kim S; Youn H; Song MG; Kang JH; Chung HK; Lee DS; Chung JK
Cancer Gene Ther; 2012 Apr; 19(4):263-70. PubMed ID: 22301953
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
Tan J; Li W; Wang P
Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter.
Carlin S; Akabani G; Zalutsky MR
J Nucl Med; 2003 Nov; 44(11):1827-38. PubMed ID: 14602867
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
17. A Novel Ideal Radionuclide Imaging System for Non-invasively Cell Monitoring built on Baculovirus Backbone by Introducing Sleeping Beauty Transposon.
Lv J; Pan Y; Ju H; Zhou J; Cheng D; Shi H; Zhang Y
Sci Rep; 2017 Mar; 7():43879. PubMed ID: 28262785
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
[TBL] [Abstract][Full Text] [Related]
19. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach.
Riesco-Eizaguirre G; De la Vieja A; Rodríguez I; Miranda S; Martín-Duque P; Vassaux G; Santisteban P
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1435-43. PubMed ID: 21697253
[TBL] [Abstract][Full Text] [Related]
20. Visualization of hypoxia-inducible factor-1 transcriptional activation in C6 glioma using luciferase and sodium iodide symporter genes.
Yeom CJ; Chung JK; Kang JH; Jeon YH; Kim KI; Jin YN; Lee YM; Jeong JM; Lee DS
J Nucl Med; 2008 Sep; 49(9):1489-97. PubMed ID: 18703592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
